Profile data is unavailable for this security.
About the company
StemRIM Inc. is a Japan-based company mainly engaged in the regenerative medicine business. The Company is engaged in the development and research of medicines based on new action mechanism to promote functional regeneration and healing of biological tissue damaged and lost function due to injury or illness. The Company’s main product is stem cell regeneration-inducing medicine. The stem cell regeneration-inducing medicine is a medicine which can obtain the same therapeutic effect as regenerative medicine only by administering the medicine without using living cells and tissues.
- Revenue in JPY (TTM)0.00
- Net income in JPY-2.02bn
- Incorporated2006
- Employees44.00
- LocationStemRIM Inc3F, Saito Bio-Incubator, 7-7-15, SaitoIBARAKI-SHI 567-0085JapanJPN
- Phone+81 726487152
- Websitehttps://stemrim.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbio Pharmaceuticals Ltd | 3.07bn | -4.02bn | 11.11bn | 109.00 | -- | 2.15 | -- | 3.62 | -92.13 | -92.13 | 70.03 | 112.55 | 0.4225 | 2.97 | 4.47 | 28,137,370.00 | -55.36 | -19.18 | -62.58 | -23.62 | 77.57 | 65.84 | -131.05 | -24.32 | 6.51 | -- | 0.00 | -- | -44.15 | 7.82 | -266.45 | -- | 42.39 | -- |
| Ohki Healthcare Holdings Co Ltd | 342.45bn | 1.87bn | 12.00bn | 632.00 | 6.26 | 0.3897 | 5.48 | 0.035 | 136.22 | 136.22 | 24,995.05 | 2,189.15 | 2.45 | 12.90 | 4.52 | 541,849,700.00 | 1.29 | 1.85 | 5.54 | 8.42 | 5.00 | 6.16 | 0.5268 | 0.7178 | 0.8641 | -- | 0.2547 | 13.92 | 9.92 | 5.30 | 1.28 | 1.51 | -5.34 | 5.92 |
| Oncolys Biopharma Inc | 31.38m | -1.91bn | 15.88bn | 34.00 | -- | 7.36 | -- | 505.85 | -94.41 | -94.41 | 1.53 | 86.36 | 0.015 | 0.00 | 0.2917 | 923,058.80 | -91.65 | -45.75 | -104.28 | -51.86 | 0.00 | 60.46 | -6,093.40 | -233.66 | 9.72 | -102.93 | 0.1442 | -- | -93.54 | -17.86 | -68.72 | -- | 28.18 | -- |
| CanBas Co Ltd (Parent) | 0.00 | -1.31bn | 16.25bn | 11.00 | -- | 5.07 | -- | -- | -72.79 | -72.79 | 0.00 | 167.60 | 0.00 | -- | -- | 0.00 | -38.05 | -62.25 | -42.35 | -70.91 | -- | -- | -- | -2,015.62 | -- | -- | -- | -- | -- | -- | 2.77 | -- | -- | -- |
| Stella Pharma Corp | 284.89m | -726.61m | 16.88bn | 44.00 | -- | 5.48 | -- | 59.25 | -22.94 | -22.94 | 8.91 | 90.49 | 0.061 | 0.0433 | 2.59 | 6,474,773.00 | -15.55 | -22.50 | -16.34 | -24.83 | 84.75 | -- | -255.05 | -488.65 | 17.82 | -563.58 | 0.217 | -- | 17.65 | -- | 1.94 | -- | -5.87 | -- |
| TAIKO PHARMACEUTICAL CO LTD | 6.28bn | -2.34bn | 18.38bn | 208.00 | -- | 2.26 | -- | 2.93 | -46.93 | -46.93 | 125.40 | 160.66 | 0.434 | 1.69 | 2.94 | 30,201,920.00 | -16.12 | -- | -19.68 | -- | 55.73 | -- | -37.15 | -- | 2.83 | -- | 0.2166 | -- | 21.43 | -- | 26.23 | -- | -- | -- |
| CellSeed Inc | 199.47m | -957.04m | 19.58bn | 35.00 | -- | 8.93 | -- | 98.16 | -30.72 | -30.72 | 6.40 | 63.29 | 0.0892 | 1.65 | 7.91 | 5,699,172.00 | -42.79 | -49.69 | -46.02 | -54.55 | 55.38 | 63.66 | -479.79 | -428.62 | 16.42 | -5,460.76 | 0.0651 | -- | 50.39 | -28.62 | -11.43 | -- | 80.73 | -- |
| Astena Holdings Co Ltd | 53.39bn | 2.09bn | 20.25bn | 1.40k | 9.39 | 0.6851 | 4.40 | 0.3792 | 52.62 | 52.62 | 1,341.82 | 721.11 | 0.7976 | 3.29 | 2.69 | 38,024,920.00 | 3.12 | 2.49 | 5.76 | 4.44 | 34.11 | 25.33 | 3.91 | 2.32 | 0.879 | 391.65 | 0.349 | 44.92 | 4.73 | -2.85 | 100.61 | -3.85 | 38.54 | 11.38 |
| StemRIM Inc | 0.00 | -2.02bn | 21.96bn | 44.00 | -- | 2.47 | -- | -- | -32.98 | -32.98 | 0.00 | 144.57 | 0.00 | -- | -- | 0.00 | -20.44 | -8.34 | -20.74 | -8.49 | -- | -- | -- | -68.74 | 131.03 | -11,344.72 | 0.00 | -- | -100.00 | -- | -1,301.17 | -- | -4.35 | -- |
| Fuso Pharmaceutical Industries Ltd | 57.72bn | 2.20bn | 24.64bn | 1.31k | 10.13 | 0.5876 | 5.50 | 0.4269 | 257.39 | 257.39 | 6,774.96 | 4,436.49 | 0.7581 | 3.07 | 2.33 | 44,163,730.00 | 2.89 | 1.91 | 4.97 | 3.09 | 26.58 | 26.92 | 3.81 | 2.69 | 0.9406 | 50.75 | 0.267 | 41.10 | 8.61 | 3.76 | -14.21 | 9.02 | 9.13 | -2.64 |
Data as of Nov 22 2024. Currency figures normalised to StemRIM Inc's reporting currency: Japanese Yen JPY
0.90%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Daiwa Asset Management Co. Ltd.as of 30 Jun 2024 | 241.00k | 0.39% |
| Simplex Asset Management Co., Ltd.as of 07 Nov 2024 | 165.40k | 0.27% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 29 Jun 2023 | 49.90k | 0.08% |
| Meiji Yasuda Asset Management Co. Ltd.as of 29 Nov 2022 | 35.00k | 0.06% |
| Schroder Investment Management (Japan) Ltd.as of 25 Oct 2023 | 32.00k | 0.05% |
| SSgA Funds Management, Inc.as of 07 Nov 2024 | 18.80k | 0.03% |
| Amundi Japan Ltd.as of 11 Sep 2023 | 3.70k | 0.01% |
| Connor, Clark & Lunn Investment Management Ltd.as of 30 Jun 2024 | 2.80k | 0.01% |
| LGT Capital Partners AG (Investment Management)as of 31 May 2024 | 2.50k | 0.00% |
| Schroder Investment Management Ltd.as of 30 Jun 2024 | 0.00 | 0.00% |
More ▼
Data from 31 Jul 2024 - 14 Nov 2024Source: FactSet Research Systems Inc.
